ACVR1 and fibrodysplasia ossificans progressiva: We present the unexpected finding that an anti-ACVR1 antibody (JAB0505) that effectively blocks ligand-dependent osteogenic reporter gene expression in cultured C2C12 cells profoundly exacerbates HO in FOP mouse models.